Abstract:Objective: This meta-analysis with a systematic review was undertaken to assess the association between APOE allelic genotypes and the risk of Alzheimer's disease (AD) in the Italian population. Methods: The Web of Science, PubMed, and Scopus databases were searched until 15 November 2023. The odds ratio (OR) with a 95% confidence interval (CI) was calculated using fixed and random effect models, depending on the I2 statistic value. The systematic review and meta-analysis were conducted in agreement with the PRISMA guideline and registered with PROSPERO (CRD42023492580). Results: Our meta-analysis based on 15 studies revealed a higher risk of AD among Italian individuals carrying the APOE ε4 allele (OR = 3.60, 95% CI [2.90–4.47], p < 0.0001). The association of AD genotype APOE ε2ε4 (OR = 1.36, 95% CI [0.76–2.41], p = 0.29) was not statistically significant, while APOE ε3ε4 (OR = 3.43, 95% CI [2.95–3.99], p < 0.0001) has a high risk of AD development; the risk is more notably in the APOE ε4ε4 genotype (OR = 7.08, 95% CI [4.22–11.86], p < 0.0001). The APOE ε2 allele has a protective effect (APOE ε2 (OR = 0.47, 95% CI [0.29-0-74], p = 0.0013)), and similar results were achieved by APOE ε3 (OR = 0.49, 95% CI [0.37–0.65], p < 0.0001). Subgroup analysis of three areas of Italy (southern, northern, and center) revealed that that APOE ε4 allele was a risk factor with a higher OR in northern Italy (OR 4.22; 95% CI [3.46–5.16], p < 0.0001) compared to southern and center Italy (OR 3.02; 95% CI [2.28–4.01], p < 0.0001 and OR 3.97; 95% CI [1.37–11.56], p < 0.0001, respectively). As well, APOE ε4ε4 genotype carriers had a significantly higher OR in northern Italy (OR 9.69; 95% CI [4.94–18.99], p < 0.0001) compared to in southern and center Italy (OR 4.38; 95% CI [1.54–12.47], p < 0.0001 and OR 3.59; 95% CI [0.87–14.86], p < 0.0001, respectively). Conclusions: This systematic review with a meta-analysis of the Italian population on APOE alleles, genotyping, and AD incidence, highlights that individuals harboring APOE ε4 have a higher risk of developing AD compared to those with other alleles. It also supports the protective effect of the APOE ε2 allele against the progress of AD. The qualitative analysis on the complex genetic interactions influencing Alzheimer risk emphasizes the need for further research on genetic and environmental factors for effective prevention strategies.

Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis

Association Study of Apolipoprotein E Gene Polymorphisms with Geriatric Depression

Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.

Associations Between Apolipoprotein E Gene Polymorphisms and Alzheimer&rsquo;s Disease Risk in a Large Chinese Han Population

Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis

Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis

Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population

Correlation between apolipoprotein E gene and Alzheimer's disease

Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.

Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis

Comparing PCR With High-resolution Melting Analysis for Apolipoprotein E Genotyping in Alzheimer's: A Case-control Study

Investigation of the Relationship between Apolipoprotein E Alleles and Serum Lipids in Alzheimer's Disease: A Meta-Analysis

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

The Application Value of ApoE Gene Polymorphism in Alzheimer's Disease

Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers

Relationship Between Apolipoprotein E Gene Polymorphism and Early-onset Alzheimer’s Disease

Effects of Apolipoprotein E Allele and Age in Alzheimer’s Disease and Mild Cognitive Impairment in a Memory Clinic Cohort in Beijing

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Expression of Apolipoprotein E in Alzheimer's Disease and Its Significance

Alzheimer Disease Associated Loci: APOE Single Nucleotide Polymorphisms in Marmara Region

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.